Today’s discoveries to tomorrow’s care: cancer biomarkers revisited
CD24, a promising biomarker in NSCLC
Novel approach for oral cancer biomarker discovery
From gene to protein expression: improving prognostication of DCIS
Company Profile: Altor BioScience Corporation
Emerging biomarkers in breast cancer care
Personalized medicine in oncology: tailoring the right drug to the right patient
Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment
Epigenomics and ovarian carcinoma
Is gene expression profiling of head and neck cancers ready for the clinic?
Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice
Modification of bladder cancer diagnostic allows simpler methylation analysis of multiple promoter CpG islands
Potential biomarker to help treat aggressive lung cancer
Imaging of white matter may help early detection of Alzheimer’s disease
Blood biomarkers: proteins to identify ovarian cancer before symptoms appear
YKL-40: a new biomarker in cardiovascular disease?
An update on markers of carotid atherosclerosis in patients with Type 2 diabetes
Chromatin conformation signatures: ideal human disease biomarkers?
C-type natriuretic-derived peptides as biomarkers in human disease
Acknowledgements
Corrigendum
Erratum